# Dapagliflozin on Volume Vascular Outcomes.

> **NCT04869124** · PHASE4 · COMPLETED · sponsor: **Frank Ruschitzka** · enrollment: 80 (actual)

## Conditions studied

- Heart Failure，Congestive

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04869124
- **Lead sponsor:** Frank Ruschitzka
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-15
- **Primary completion:** 2024-09-26
- **Final completion:** 2024-10-28
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04869124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04869124, "Dapagliflozin on Volume Vascular Outcomes.". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04869124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*